Patents by Inventor Jennifer Rolland
Jennifer Rolland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220088159Abstract: The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with T lymphocytes in subjects having peanut allergy, or allergy to other tree nuts, and genetic sequences encoding same. These molecules are preferably immunointeractive with T cells in subjects having an allergy to the Ara h 1 allergen. The molecules of the present invention are useful in the development of diagnostic, therapeutic and prophylactic agents for conditions characterised by an aberrant, inappropriate or otherwise unwanted immune response to Ara h 1 or derivative or homologue thereof.Type: ApplicationFiled: July 13, 2021Publication date: March 24, 2022Inventors: Robyn O'Hehir, Jennifer Rolland, Sara Prickett
-
Patent number: 11096994Abstract: The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with T lymphocytes in subjects having peanut allergy, or allergy to other tree nuts, and genetic sequences encoding same. These molecules are preferably immunointeractive with T cells in subjects having an allergy to the Ara h 1 allergen. The molecules of the present invention are useful in the development of diagnostic, therapeutic and prophylactic agents for conditions characterised by an aberrant, inappropriate or otherwise unwanted immune response to Ara h 1 or derivative or homologue thereof.Type: GrantFiled: October 30, 2013Date of Patent: August 24, 2021Assignee: ARAVAX PTY LTDInventors: Robyn O'Hehir, Jennifer Rolland, Sara Prickett
-
Patent number: 10293042Abstract: The present invention relates generally to novel recombinant polypeptides of Bahia grass pollen and to genetic sequences encoding same. More particularly, the present invention is directed to Pas n 1 polypeptides and derivatives, and fragments thereof and genetic sequences encoding same. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications including, but not limited to, applications in the context of conditions characterized by an aberrant, inappropriate or otherwise unwanted immune response to the Bahia grass pollen.Type: GrantFiled: September 14, 2017Date of Patent: May 21, 2019Assignee: QUEENSLAND UNIVERSITY OF TECHNOLOGYInventors: Robyn O'Hehir, Janet Davies, Jennifer Rolland
-
Publication number: 20180214539Abstract: The present invention relates generally to novel recombinant polypeptides of Bahia grass pollen and to genetic sequences encoding same. More particularly, the present invention is directed to Pas n 1 polypeptides and derivatives, and fragments thereof and genetic sequences encoding same. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications including, but not limited to, applications in the context of conditions characterized by an aberrant, inappropriate or otherwise unwanted immune response to the Bahia grass pollen.Type: ApplicationFiled: September 14, 2017Publication date: August 2, 2018Inventors: Robyn O'Hehir, Janet Davies, Jennifer Rolland
-
Patent number: 9789177Abstract: The present invention relates generally to novel recombinant polypeptides of Bahia grass pollen and to genetic sequences encoding same. More particularly, the present invention is directed to Pas n 1 polypeptides and derivatives, and fragments thereof and genetic sequences encoding same. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications including, but not limited to, applications in the context of conditions characterized by an aberrant, inappropriate or otherwise unwanted immune response to the Bahia grass pollen.Type: GrantFiled: June 23, 2014Date of Patent: October 17, 2017Assignee: Queensland University of TechnologyInventors: Robyn O'Hehir, Janet Davies, Jennifer Rolland
-
Publication number: 20150328294Abstract: The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with T lymphocytes in subjects having peanut allergy, or allergy to other tree nuts, and genetic sequences encoding same. These molecules are preferably immunointeractive with T cells in subjects having an allergy to the Ara h 1 allergen. The molecules of the present invention are useful in the development of diagnostic, therapeutic and prophylactic agents for conditions characterised by an aberrant, inappropriate or otherwise unwanted immune response to Ara h 1 or derivative or homologue thereof.Type: ApplicationFiled: October 30, 2013Publication date: November 19, 2015Inventors: Robyn O'HEHIR, Jennifer ROLLAND, Sara PRICKETT
-
Patent number: 9120865Abstract: The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with T lymphocytes in subjects having Bermuda grass allergy and genetic sequences encoding same. These molecules are preferentially immunointeractive with T cells in subjects having a Bermuda grass pollen allergy. The molecules of the present invention are useful in the development of diagnostic, therapeutic and prophylactic agents for conditions characterized by an aberrant, inappropriate or otherwise unwanted immune response to Bermuda grass pollen or derivative or homolog thereof.Type: GrantFiled: August 30, 2010Date of Patent: September 1, 2015Assignee: Circassia LimitedInventors: Robyn O'Hehir, Jennifer Rolland
-
Publication number: 20140302073Abstract: The present invention relates generally to novel recombinant polypeptides of Bahia grass pollen and to genetic sequences encoding same. More particularly, the present invention is directed to Pas n 1 polypeptides and derivatives, and fragments thereof and genetic sequences encoding same. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications including, but not limited to, applications in the context of conditions characterised by an aberrant, inappropriate or otherwise unwanted immune response to the Bahia grass pollen.Type: ApplicationFiled: June 23, 2014Publication date: October 9, 2014Inventors: Robyn O'Hehir, Janet Davies, Jennifer Rolland
-
Patent number: 8057800Abstract: The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with T lymphocytes in subjects having peanut allergy, or allergy to other tree nuts, and genetic sequences encoding same. These molecules are preferentially immunointeractive with T cells in subjects having an allergy to the Ara h 2 allergen. The molecules of the present invention are useful in the development of diagnostic, therapeutic and prophylactic agents for conditions characterized by an aberrant, inappropriate or otherwise unwanted immune response to Ara h 2 or derivative or homologue thereof.Type: GrantFiled: June 10, 2005Date of Patent: November 15, 2011Assignee: Circassia LimitedInventors: Robyn O'Hehir, Jennifer Rolland
-
Publication number: 20110217325Abstract: The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with T lymphocytes in subjects having Bermuda grass allergy and genetic sequences encoding same. These molecules are preferentially immunointeractive with T cells in subjects having a Bermuda grass pollen allergy. The molecules of the present invention are useful in the development of diagnostic, therapeutic and prophylactic agents for conditions characterised by an aberrant, inappropriate or otherwise unwanted immune response to Bermuda grass pollen or derivative or homologue thereof.Type: ApplicationFiled: August 30, 2010Publication date: September 8, 2011Applicant: CIRCASSIA LIMITEDInventors: Robyn O'HEHIR, Jennifer ROLLAND
-
Publication number: 20110014292Abstract: The present invention relates generally to a method of prophylactically or therapeutically treating antigen-induced airway tissue inflammation and agents for use therein. More particularly, the present invention provides a method of prophylactically or therapeutically treating allergic airway inflammation and agents for use therein via the administration of the method of the present invention is useful, inter alia, in the treatment and/or prophylaxis of conditions characterised by antigen-induced airway tissue inflammation.Type: ApplicationFiled: October 15, 2008Publication date: January 20, 2011Applicant: COOPERATIVE RESEARCH CENTRE FOR ASTHMAInventors: Robyn Elizabeth O'Hehir, Magda Plebanski, Jennifer Rolland, Charles Linton Hardy
-
Publication number: 20110014238Abstract: The present invention relates generally to novel recombinant polypeptides of Bahia grass pollen and to genetic sequences encoding same. More particularly, the present invention is directed to Pas n 1 polypeptides and derivatives, and fragments thereof and genetic sequences encoding same. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications including, but not limited to, applications in the context of conditions characterised by an aberrant, inappropriate or otherwise unwanted immune response to the Bahia grass pollen.Type: ApplicationFiled: October 21, 2008Publication date: January 20, 2011Applicant: COOPERATIVE RESEARCH CENTRE FOR ASTHMAInventors: Robyn O'Hehir, Janet Davies, Jennifer Rolland
-
Publication number: 20080075725Abstract: The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with T lymphocytes in subjects having peanut allergy, or allergy to other tree nuts, and genetic sequences encoding same. These molecules are preferentially immunointeractive with T cells in subjects having an allergy to the Ara h 2 allergen. The molecules of the present invention are useful in the development of diagnostic, therapeutic and prophylactic agents for conditions characterised by an aberrant, inappropriate or otherwise unwanted immune response to Ara h 2 or derivative or homologue thereof.Type: ApplicationFiled: June 10, 2005Publication date: March 27, 2008Applicant: Monash UniversityInventors: Robyn O'Hehir, Jennifer Rolland
-
Publication number: 20060084789Abstract: The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with T lymphocytes in subjects having Rye grass pollen allergy and genetic sequences encoding same. These molecules are preferentially immunointeractive with T cells in subjects having a Rye grass pollen allergy. The molecules of the present invention are useful in the development of diagnostic, therapeutic and prophylactic agents for conditions characterised by an aberrant, inappropriate or otherwise unwanted immune response to Rye grass pollen or derivative or homologue thereof.Type: ApplicationFiled: April 2, 2003Publication date: April 20, 2006Inventors: Robyn O'Hehir, Jennifer Rolland
-
Publication number: 20050075481Abstract: The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with T cell lymphocytes in subjects having Bermuda grass allergy and genetic sequences encoding same. These molecules are preferentially immunointeractive with T cells in subjects having a Bermuda grass pollen allergy. The molecules of the present invention are useful in the development of diagnostic, therapeutic and prophylactic agents for conditions characterised by an aberrant, inappropriate or otherwise unwanted immune response to Bermuda grass pollen or derivative or homologue thereof.Type: ApplicationFiled: September 18, 2002Publication date: April 7, 2005Inventors: Robyn O'Hehir, Jennifer Rolland